Annexin A1 is known to have beneficial effects in islets by potentiating glucose‐stimulated insulin release and protecting against apoptosis,22 so its secretion from expanded adipose depots in obesity may lead to improved islet function via binding to the formylpeptide receptor FPR2. Here, ANXA1 is linked to obesity disorder.